Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers
- 16 October 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Esophagus
- Vol. 49 (8), 1274-1284
- https://doi.org/10.1007/s00535-013-0890-2
Abstract
Background It is known that malignant transformation to hepatocellular carcinoma (HCC) occurs at a higher frequency in hepatocellular adenoma (HCA) from type I glycogen storage disease (GSD I) compared to HCA from other etiologies. In this study, we aimed to identify differentially expressed miRNAs in GSD Ia HCA as candidates that could serve as putative biomarkers for detection of GSD Ia HCA and/or risk assessment of malignant transformation. Methods Utilizing massively parallel sequencing, the miRNA profiling was performed for paired adenomas and normal liver tissues from seven GSD Ia patients. Differentially expressed miRNAs were validated in liver tumor tissues, HCC cell lines and serum using quantitative RT-PCR. Results miR-34a, miR-34a*, miR-224, miR-224*, miR-424, miR-452 and miR-455-5p were found to be commonly deregulated in GSD Ia HCA, general population HCA, and HCC cell lines at compatible levels. In comparison with GSD Ia HCA, the upregulation of miR-130b and downregulation of miR-199a-5p, miR-199b-5p, and miR-214 were more significant in HCC cell lines. Furthermore, serum level of miR-130b in GSD Ia patients with HCA was moderately higher than that in either GSD Ia patients without HCA or healthy individuals. Conclusion We make the first observation of distinct miRNA deregulation in HCA associated with GSD Ia. We also provide evidence that miR-130b could serve as a circulating biomarker for detection of GSD Ia HCA. This work provides prominent candidate miRNAs worth evaluating as biomarkers for monitoring the development and progress of liver tumors in GSD Ia patients in the future.This publication has 50 references indexed in Scilit:
- Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort studyBMJ Open, 2012
- miRBase: integrating microRNA annotation and deep-sequencing dataNucleic Acids Research, 2010
- Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasionMolecular Cancer, 2010
- Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinomaHepatology, 2010
- miR-221 overexpression contributes to liver tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 2010
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient SurvivalClinical Cancer Research, 2008
- MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular CancerGastroenterology, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- MicroRNAs Modulate Hematopoietic Lineage DifferentiationScience, 2004